Otros idiomas Captor Therapeutics Spolka Akcyjna

Acciones

CTX

PLCPTRT00014

Mercado cerrado - Warsaw S.E. Otros sitios de cotización 17:55:47 04/07/2024			Varia. Cinco días.	Varia. 1 de enero.
71,8 ^PLN	-2,45 %		-9,34 %	-27,47 %

29/05	Captor Therapeutics Spolka Akcyjna informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
2023	Captor Therapeutics Spolka Akcyjna presenta los resultados de los nueve meses finalizados el 30 de septiembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the First Quarter Ended March 31, 2024	29/05
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Nine Months Ended September 30, 2023	28/11
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2023	07/09/23
Captor Therapeutics Publishes Q1 2023 Financial Results	30/05/23
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the First Quarter Ended March 31, 2023	29/05/23
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2022	06/04/23
Captor Therapeutics Discloses Molecular Targets of Pipeline’s Lead Assets and Invites Stakeholders to Webcast	28/03/23
Captor Therapeutics Announces Three-Year Strategic Objectives	07/03/23
Captor Therapeutics Reports Q3 2022 Results and Provides Business UpdateLead assets approaching the clinic and new significant drug discovery collaboration signed with Ono Pharmaceutical	28/11/22
Captor Therapeutics Reports Q3 2022 Results and Provides Business Update	25/11/22
Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	24/11/22
Ono Enters a Drug Discovery Collaboration Agreement with Captor Therapeutics to Develop Small Molecule Protein Degraders for the Treatment of Neurodegenerative Diseases	15/11/22
Ono Pharmaceutical and Captor Therapeutics Announce Drug Discovery Collaboration to Develop Small Molecule Protein Degraders for the Treatment of Neurodegenerative Diseases	14/11/22
Ono Pharmaceutical and Captor Therapeutics Announces Drug Discovery Collaboration to Develop Small Molecule Protein Degraders for the Treatment of Neurodegenerative Diseases	14/11/22
Captor Therapeutics Nominates the Molecular Glue CPT-6281 as Drug Candidate to Enter CTA/IND-Enabling Studies for the Treatment of Hepatocellular Carcinoma	10/08/22
Captor Therapeutics S.A. Nominates the Molecular Glue CPT-6281 as Drug Candidate to Enter CTA/IND-Enabling Studies for the Treatment of Hepatocellular Carcinoma	10/08/22
Captor Therapeutics to Host R&D Day on May 18, 2022	05/05/22
Captor Therapeutics to Host R&D Day on May 18, 2022	05/05/22
Captor Therapeutics announces molecular targets of CT-01 program developing TPD therapy for hepatocellular carcinoma	12/04/22
Captor Therapeutics S.A. Announces Molecular Targets of CT-01 Program Developing TPD Therapy for Hepatocellular Carcinoma	12/04/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Captor Therapeutics Spolka Akcyjna

Acciones

CTX

PLCPTRT00014

Otros idiomas

Filtros